CME and CFTC Clash Over On-Chain Perpetual Futures

The CME Group, the largest derivatives exchange operator in the US, has found itself at odds with its regulator, the Commodity Futures Trading Commission, over the agency's decision to allow blockchain-based perpetual futures products. This unusual conflict began when the CFTC approved the listing of crypto perpetual futures, also known as perps, on the prediction markets platform Kalshi and cryptocurrency exchange Coinbase. The CME has since sued the CFTC and its chairman, Mike Selig, challenging the decision and arguing that these products are harmful to its long-dated futures products. The lawsuit claims that the CFTC is mislabeling perps and misapplying the law, as futures are required to have an end date, whereas perps are designed for traders to take a financial position on an asset's future without any deadlines. The CME's stance has sparked frustration among those supporting the CFTC's reforming agenda, with some viewing the exchange's actions as an attempt to maintain its dominance in the market. The dispute has significant implications for the rapidly growing perps market, with non-US perps volume reportedly reaching $60 trillion in volume last year. As the case awaits federal court action, the CFTC's approach to regulating perps remains uncertain, with the agency's decision to allow these products sparking debate over the definition of swaps and futures, and the regulatory and tax regimes that apply to them. The CME's influence over commodities and its role in shaping US policy on crypto and derivatives will likely be crucial in determining the outcome of this battle.